# A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Study · id `cardio:ct-nct05824923` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05824923](<https://clinicaltrials.gov/study/NCT05824923>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05824923

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 264 participants.

## Technical summary

Registry record NCT05824923. Randomized; single masking; primary purpose treatment. Start 2023-08-14 (actual); primary completion 2025-08-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 264 participants (planned count; ClinicalTrials.gov record NCT05824923, source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)
- Started: 2023-08-14 (actual) (ClinicalTrials.gov record NCT05824923, source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)
- Primary completion: 2025-08-27 (actual) (ClinicalTrials.gov record NCT05824923, source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)
- Completion: 2027-02 (anticipated) (ClinicalTrials.gov record NCT05824923, source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05824923, source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05824923-2026-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
- Acronym: PADN-HF-PH
- Condition: Pulmonary Hypertension
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Condition: Heart Failure
- Condition: Heart Failure With Preserved Ejection Fraction
- Condition: Heart Failure With Mid Range Ejection Fraction
- Intervention (Procedure): Pulmonary arterial denervation
- Intervention (Drug): Guideline-directed medical therapy (GDMT) for heart failure
- Lead sponsor: Pulnovo Medical (Wuxi) Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: The General Hospital of Northern Theater Command
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital with Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: First Hospital of Tsinghua University
- Collaborator class: OTHER
- Collaborator: Cangzhou Central Hospital
- Collaborator class: OTHER
- Collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Guangzhou Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: Tongji Hospital
- Collaborator class: OTHER
- Collaborator: Second Hospital of Jilin University
- Collaborator class: OTHER
- Collaborator: China-Japan Union Hospital, Jilin University
- Collaborator class: OTHER
- Collaborator: Shanxi Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: RenJi Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai 10th People's Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: Sichuan Academy of Medical Sciences
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Soochow University
- Collaborator class: OTHER
- Collaborator: TEDA International Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: Tianjin Medical University General Hospital
- Collaborator class: OTHER
- Collaborator: Renmin Hospital of Wuhan University
- Collaborator class: OTHER
- Collaborator: Zhongnan Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital Xi'an Jiaotong University
- Collaborator class: OTHER
- Collaborator: Xiamen Cardiovascular Hospital, Xiamen University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Zhejiang University
- Collaborator class: OTHER
- Collaborator: Shengjing Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Fujian Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Wenzhou Medical University
- Collaborator class: OTHER
- Collaborator: Gansu Provincial Hospital
- Collaborator class: OTHER
- Collaborator: Yan'an Affiliated Hospital of Kunming Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER
- Collaborator: Huaihe Hospital of Henan University
- Collaborator class: OTHER
- Collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Nanchang University
- Collaborator class: OTHER
- Collaborator: Hunan Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: Tianjin Medical University Second Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital, Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: The First Hospital of Jilin University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 30 registry organizations

## Provenance

Content hash: 285d469e8cf29577ef68cf9082992984e471f2f46f376b7c6de2e25ff21149c5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
